336 related articles for article (PubMed ID: 15182426)
1. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents.
Takahashi M; Wakabayashi K
Cancer Sci; 2004 Jun; 95(6):475-80. PubMed ID: 15182426
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
3. Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.
Kohno H; Suzuki R; Sugie S; Tanaka T
Cancer Sci; 2005 Feb; 96(2):69-76. PubMed ID: 15723650
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
5. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
6. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
7. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.
Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K
Carcinogenesis; 2005 Jan; 26(1):229-38. PubMed ID: 15459021
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
9. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.
Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H
Cancer Lett; 2002 Sep; 183(1):31-41. PubMed ID: 12049812
[TBL] [Abstract][Full Text] [Related]
10. Brewers' rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats.
Tan BL; Norhaizan ME; Huynh K; Yeap SK; Hazilawati H; Roselina K
World J Gastroenterol; 2015 Aug; 21(29):8826-35. PubMed ID: 26269672
[TBL] [Abstract][Full Text] [Related]
11. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.
Tanaka T; Kohno H; Suzuki R; Yamada Y; Sugie S; Mori H
Cancer Sci; 2003 Nov; 94(11):965-73. PubMed ID: 14611673
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
14. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.
Yamada Y; Oyama T; Hirose Y; Hara A; Sugie S; Yoshida K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):91-7. PubMed ID: 12538353
[TBL] [Abstract][Full Text] [Related]
16. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors.
Takahashi M; Fukuda K; Sugimura T; Wakabayashi K
Cancer Res; 1998 Jan; 58(1):42-6. PubMed ID: 9426055
[TBL] [Abstract][Full Text] [Related]
19. COX-2 and iNOS, good targets for chemoprevention of colon cancer.
Watanabe K; Kawamori T; Nakatsugi S; Wakabayashi K
Biofactors; 2000; 12(1-4):129-33. PubMed ID: 11216473
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]